Rickard E Malmström

Summary

Affiliation: Karolinska Institutet
Country: Sweden

Publications

  1. pmc Personalizing health care: feasibility and future implications
    Brian Godman
    Department of Laboratory Medicine, Division of Clinical Pharmacology, Karolinska Institutet, Karolinska University Hospital Huddinge, SE 141 86, Stockholm, Sweden
    BMC Med 11:179. 2013
  2. ncbi request reprint No effect of lipid lowering on platelet activity in patients with coronary artery disease and type 2 diabetes or impaired glucose tolerance
    Rickard E Malmström
    Department of Medicine Solna, Clinical Pharmacology Unit, Karolinska University Hospital Solna, SE 171 76 Stockholm, Sweden
    Thromb Haemost 101:157-64. 2009
  3. doi request reprint Influence of statin treatment on platelet inhibition by clopidogrel - a randomized comparison of rosuvastatin, atorvastatin and simvastatin co-treatment
    Rickard E Malmström
    Clinical Pharmacology, Department of Medicine Solna, Karolinska Institutet and Karolinska University Hospital Solna, Stockholm, Sweden
    J Intern Med 266:457-66. 2009
  4. doi request reprint Endothelin attenuates endothelium-dependent platelet inhibition in man
    R E Malmstrom
    Department of Medicine, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden
    Acta Physiol (Oxf) 198:441-8. 2010

Collaborators

  • John Pernow
  • Felix Bohm
  • M Settergren
  • Leif Jørgensen
  • Brian Godman
  • Andrew Martin
  • Ken Paterson
  • Christina Kvalheim
  • Kamila Malinowska
  • Vera Vlahovic-Palcevski
  • Alexander E Finlayson
  • Stephen Campbell
  • Harald Herholz
  • Gisbert Selke
  • Marija Kalaba
  • Katharine Harris
  • Fredrik Nilsson
  • Durhane Wong-Rieger
  • Marion Bennie
  • Dominik Tomek
  • Catherine Sermet
  • Jan Jones
  • Steven Simoens
  • Anna Bucsics
  • Magdalena Wladysiuk
  • Luka Voncina
  • Eduardo Diogène
  • Raghib Ali
  • Corrine Zara
  • Eva Zebedin-Brandl
  • Kristina Garuoliene
  • Alan Haycox
  • Lars L Gustafsson
  • Jurij Fürst
  • Ott Laius
  • Saira Jan
  • Laura McCullagh
  • Sven Äke Lööv
  • Krystyna Hviding
  • Menno van Woerkom
  • Ulrich Schwabe
  • Miguel Gomes
  • Elina Asola
  • Iñaki Gutierrez-Ibarluzea
  • Alessandra Ferrario
  • Parneet K Cheema
  • Iain Bishop
  • Christoph Baumgärtel

Detail Information

Publications4

  1. pmc Personalizing health care: feasibility and future implications
    Brian Godman
    Department of Laboratory Medicine, Division of Clinical Pharmacology, Karolinska Institutet, Karolinska University Hospital Huddinge, SE 141 86, Stockholm, Sweden
    BMC Med 11:179. 2013
    ..Overall, personalized medicine has the potential to revolutionize care. However, current challenges and concerns need to be addressed to enhance its uptake and funding to benefit patients. ..
  2. ncbi request reprint No effect of lipid lowering on platelet activity in patients with coronary artery disease and type 2 diabetes or impaired glucose tolerance
    Rickard E Malmström
    Department of Medicine Solna, Clinical Pharmacology Unit, Karolinska University Hospital Solna, SE 171 76 Stockholm, Sweden
    Thromb Haemost 101:157-64. 2009
    ....
  3. doi request reprint Influence of statin treatment on platelet inhibition by clopidogrel - a randomized comparison of rosuvastatin, atorvastatin and simvastatin co-treatment
    Rickard E Malmström
    Clinical Pharmacology, Department of Medicine Solna, Karolinska Institutet and Karolinska University Hospital Solna, Stockholm, Sweden
    J Intern Med 266:457-66. 2009
    ..Possible interactions between clopidogrel and atorvastatin, simvastatin or rosuvastatin (a 'non-CYP3A4' metabolized statin) were investigated in a randomized prospective study using sensitive and specific ex vivo platelet function tests...
  4. doi request reprint Endothelin attenuates endothelium-dependent platelet inhibition in man
    R E Malmstrom
    Department of Medicine, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden
    Acta Physiol (Oxf) 198:441-8. 2010
    ..Experiments were designed to investigate the effect of ET-1 on endothelium-dependent vasodilatation and attenuation of platelet activation...